Liquid Biopsy in Ewing Sarcoma and Osteosarcoma as a Prognostic And Response Diagnostic: LEOPARD

Clinical trial NCT06068075 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06068075
Sponsor: Dana-Farber Cancer Institute
Status: ACTIVE_NOT_RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Ewing Sarcoma Ewing Sarcoma of Bone Ewing Sarcoma of Soft Tissue Peripheral Primitive Neuroectodermal Tumor Peripheral Primitive Neuroectodermal Tumor of Bone Peripheral Primitive Neuroectodermal Tumor of Soft Tissue High-grade Osteosarcoma

Start date: 2018-05-08
Primary completion: 2027-01-01
Enrollment: 340

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.